Recent Articles By The Author
Don't Expect First Quarter Earnings to Come to the Rescue
I don't see a major sustainable rally on the near-term horizon to rescue beaten up investors.
Is it Time to Sell in May and Go Away?
Let's recap some of the main worries behind the selloff. Unfortunately, I think the trading action gets worse before it gets better.
I'm Cautiously Adding Homebuilder Exposure: Here's My Favorite Play
The large decline in the sector is starting to bring many names back down to more than reasonable valuations.
The Timing Is Right to Add to These 2 Holdings
As we close out another volatile trading week, let's strike a more optimistic tune.
Economic Stresses Now and to Come Make Most Equities Unappealing
Reduced global growth expectations amid war, inflation and supply chain issues should give investors pause.
Checking Out Insider Buying of 2 Stocks, Including a Household Name
Construction supplies distributor GMS Inc. and auto giant Ford Motor have seen recent substantial purchases by insiders.
Here Are 4 Opportunities Within a Very Challenging Market
The Russia invasion of Ukraine has ramifications that might turn out to be a significant tail wind for uranium producers.
The Time for Inflation to Be Resolved Benignly Has Passed
The possibility of a recession in the quarters ahead cannot be dismissed.
It's Stagflation All Over Again
If this period plays out similarly to some four decades ago, investors can expect PE multiples to contract significantly for the overall market.
BioXcel Therapeutics: Here's Why I'm Buying and How You Can Trade It
After receiving an FDA approval, the small-cap biotech looks well positioned as a covered call candidate.